Published in Cancer Weekly, April 1st, 2003
Researchers from France "analyzed data for 213 patients with ALL and AML who received either peripheral blood stem cells (PBSC) (n = 74) or bone marrow (BM) (n = 139) from an HLA-matched unrelated donor (EBMT acute leukemia registry; January 1994 to January 1999)."
"The two groups of patients (by cell source) were comparable with respect to age, sex, disease status, year at transplant and graft T-cell depletion," according to L. Garderet and coauthors at Hopital St. Antoine. "Engraftment was achieved in about...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.